Osiris Therapeutics(美国)

Osiris Therapeutics

美国OsirisTherapeuticswww.osiristx.com美国Osiris关注与间质干细胞地位（MSC）的技术，职前临床，在疾病的动物模型，并在诊所也。近年来，该公司赞助了一些临床试验，以评估产品的安全性和有效性。OsirisTherapeutics,Inc.hasfocusedontheadvancementofmesenchymalstemcell(MSC)technologie sbothpre-clinically,inanimalmodelsofdisease,andalsointheclinic.Inrecentyears,theCompanyhassponsoredanumberofclinicaltrialstoevaluateproductsafetyandefficacy.Theprimarythrustofthenear-termbusinessstrategyrevolvesaroundtheclinicaldevelopmentofproductcandidatesinavarietyofindications.Theinflammatoryprogramfocusesonprovidingsupportforbonemarrowtransplantationafterchemotherapyorradiationtherapy.Thegoalistotreatgraftversushostdisease(GvHD),alife-threateningcomplicationfollowingthereceiptofbonemarrowfromanotherindividual.ThecardiacprogramfocusesonMSCstoimproveheartfunctionfollowingmyocardialinfarction(MI)andtopreventprogressiontocongestive